Shilpy Jha

TL;DR: FNAC is an excellent procedure to differentiate benign from malignant tumors, and MSRSGC is a useful system for risk assessment and deciding the further treatment protocol, according to the cytohistological concordance and ROM calculated based on the clinical and histopathological follow-up.

TL;DR: Recurrent tuberous sclerosis / MTOR pathway gene alterations in LOT supports its consideration as a distinct morphologic, immunohistochemical, and genetic entity, and PIK3CA is another pathway member that may be altered in these tumors.

TL;DR: The International System for Reporting Serous Fluid Cytopathology (ISRSFC) was proposed by the International Academy of Cytology and the American Society of Cytopathy as discussed by the authors.

TL;DR: This work depicts the second case of primary colonic liposarcomatosis in a 57-year-old female who presented with abdominal swelling and pain and shows the morphology of well-differentiated lipOSarcoma.

TL;DR: Based on the experience with the largest series to date and aggregate of published data, ES/round cell sarcomas with EWSR1 rearrangement occurring in the bladder have bimodal age distribution with poor prognosis despite aggressive therapy.